Results 141 to 150 of about 9,493 (159)

Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease

Journal of Infection, 2020
Page E Crew, Lucy A Mcnamara
exaly  

Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome

CKJ: Clinical Kidney Journal, 2017
Tina Dutt, Karine Hadaya, Christoph Gasteyger   +2 more
exaly  

Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders

Clinical and Experimental Immunology, 2017
B Hoppe, K Kentouche, R Weimer
exaly  

Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use

Pediatric Nephrology, 2018
Kioa L Wijnsma, Caroline Duineveld, Jack F M Wetzels   +2 more
exaly  

Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review

International Journal of Hematology, 2016
Osamu Miura, Kensuke Usuki, Kaichi Nishiwaki   +2 more
exaly  

Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case Series

Clinical Infectious Diseases, 2019
Page E Crew, Robert D Kirkcaldy, Emily J Weston   +2 more
exaly  

Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis

Muscle and Nerve, 2019
Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar   +2 more
exaly  

Eculizumab

Reactions Weekly, 2017
  +4 more sources

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation, 2016
Sonata Jodele, Tsuyoshi Fukuda, Alexander A Vinks   +2 more
exaly  

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome

Kidney International Reports, 2019
Nicole Isbel, Johan Vande Walle, David J Cohen   +2 more
exaly